TREATMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA WITH INTERMEDIATE-DOSE CYTOSINE-ARABINOSIDE AND ADRIAMYCIN

被引：8
|
作者：
ISHII, E
HARA, T
OHKUBO, K
MATSUZAKI, A
TAKEUCHI, T
UEDA, K
机构：
来源：
MEDICAL AND PEDIATRIC ONCOLOGY | 1986年 / 14卷 / 02期
关键词：
D O I：
10.1002/mpo.2950140203
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：73 / 77
页数：5
相关论文
共 50 条
  • [31] IDARUBICIN AND HIGH-DOSE CYTOSINE-ARABINOSIDE (ARA-C) IN REFRACTORY ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) PATIENTS
    SPIRITI, MAA
    TESTI, AM
    AMADORI, S
    DEFABRITIIS, P
    GIONA, F
    SANDRELLI, A
    MELONI, G
    ACTA HAEMATOLOGICA, 1987, 78 : 213 - 213
  • [32] TREATMENT OF MINIMAL RESIDUAL DISEASE IN POOR RISK ACUTE LYMPHOBLASTIC-LEUKEMIA WITH HIGH-DOSE CYTOSINE-ARABINOSIDE (ARA-C)
    BARNETT, MJ
    KINGSTON, JE
    MILLER, A
    GOFF, LK
    GANESAN, TS
    BIRULS, R
    ROHATINER, AZS
    MALPAS, JS
    LISTER, TA
    LEUKEMIA RESEARCH, 1986, 10 (01) : 90 - 90
  • [33] MITOXANTRONE AND INTERMEDIATE-DOSE CYTOSINE-ARABINOSIDE FOR POOR-RISK ACUTE LEUKEMIAS - RESPONSE TO TREATMENT AND FACTORS INFLUENCING OUTCOME
    SIERRA, J
    GRANENA, A
    BOSCH, F
    CARRERAS, E
    MARTI, JM
    URBANOISPIZUA, A
    ROVIRA, M
    ROZMAN, C
    HEMATOLOGICAL ONCOLOGY, 1992, 10 (06) : 301 - 309
  • [34] COMPARISON OF EFFECTS ON CYTOSINE-ARABINOSIDE, OF CYTOSINE-ARABINOSIDE AND THIOGUANINE, AND CYTOSINE-ARABINOSIDE AND DAUNOMYCIN IN ACUTE MYELOID LEUKEMIA
    MALPAS, J
    MATHE, G
    HAYAT, M
    BULLETIN DU CANCER, 1974, 61 (03) : 411 - 418
  • [35] EXPERIENCE WITH INTERMEDIATE AND HIGH-DOSE CYTOSINE-ARABINOSIDE IN REFRACTORY ACUTE-LEUKEMIA
    WILLEMZE, R
    FIBBE, WE
    ZWAAN, FE
    ONKOLOGIE, 1983, 6 (04): : 200 - 204
  • [36] SIDE-EFFECTS OF INTERMEDIATE-DOSE AND HIGH-DOSE CYTOSINE-ARABINOSIDE IN THE TREATMENT OF REFRACTORY OR RELAPSED ACUTE-LEUKEMIA AND NON-HODGKINS-LYMPHOMA
    PETERS, WG
    WILLEMZE, R
    COLLY, LP
    GUIOT, HFL
    NETHERLANDS JOURNAL OF MEDICINE, 1987, 30 (1-2): : 64 - 74
  • [37] RELAPSE IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA AFTER ELECTIVE CESSATION OF INITIAL TREATMENT - FAILURE OF SUBSEQUENT TREATMENT WITH CYCLOPHOSPHAMIDE, CYTOSINE-ARABINOSIDE, VINCRISTINE AND PREDNISONE (COAP)
    SALLAN, SE
    HITCHCOCKBRYAN, S
    MEDICAL AND PEDIATRIC ONCOLOGY, 1981, 9 (05): : 455 - 462
  • [38] PULMONARY TOXICITY OF HIGH-DOSE AND INTERMEDIATE-DOSE CYTOSINE-ARABINOSIDE THERAPY - A RETROSPECTIVE ANALYSIS
    DIERLAMM, J
    HAUBOLDREUTER, B
    WEH, HJ
    SCHAFER, H
    HOSSFELD, DK
    ONKOLOGIE, 1994, 17 (02): : 158 - 164
  • [39] HIGH-DOSE CYTOSINE-ARABINOSIDE FOR THE TREATMENT OF RESISTANT ACUTE-LEUKEMIA
    WITZ, F
    OLIVE, D
    LEDERLIN, P
    BORDIGONI, P
    TROUSSARD, X
    GROSBOIS, B
    SCHAISON, G
    CORNU, G
    PRESSE MEDICALE, 1987, 16 (04): : 159 - 162
  • [40] LOW-DOSE CYTOSINE-ARABINOSIDE IN THE TREATMENT OF ACUTE MYELOID-LEUKEMIA
    MANOHARAN, A
    PATHOLOGY, 1984, 16 (03) : 352 - 353
12345